Immunomodulators and Immunosuppressants for Japanese Patients with Ulcerative Colitis
Author Information
Author(s): Bamba Shigeki, Tsujikawa Tomoyuki, Sasaki Masaya, Fujiyama Yoshihide, Andoh Akira
Primary Institution: Shiga University of Medical Science
Hypothesis
The study investigates the efficacy and characteristics of immunomodulators and immunosuppressants in treating steroid-refractory or steroid-dependent ulcerative colitis in Japanese patients.
Conclusion
Immunomodulators and immunosuppressants are effective alternatives for managing ulcerative colitis in Japanese patients, with specific considerations for dosing and treatment strategies.
Supporting Evidence
- The response rate at 2 weeks after CSA administration was 71%.
- Quality of life analyses showed that CSA patients scored as well as or better than those who underwent colectomies.
- The addition of azathioprine after CSA treatment significantly reduced the colectomy rate.
Takeaway
This study looks at how certain medicines can help people in Japan with a gut problem called ulcerative colitis when other treatments don't work.
Methodology
The study reviewed medical charts and follow-ups of patients treated with cyclosporine A and other immunomodulators for ulcerative colitis.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the limited sample size.
Limitations
The clinical data on cyclosporine A in Japanese patients are limited, and the study does not include experiences with methotrexate or anti-TNFα-antibody.
Participant Demographics
The study focuses on Japanese patients with ulcerative colitis.
Statistical Information
P-Value
P = .0237
Confidence Interval
95% confidence interval 1.03–19.57
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website